Modifying disability in progressive multiple sclerosis

Modifying disability in progressive multiple sclerosis

Veure altres versions (1)

Dades bibliogràfiques
Autors principals:	Palace, J, Robertson, N
Format:	Journal article
Idioma:	English
Publicat:	Lancet 2014

Ítems similars

Modifying disability in progressive multiple sclerosis.
per: Palace, J, et al.
Publicat: (2014)

Brain reserve and physical disability in secondary progressive multiple sclerosis
per: Nevin John, et al.
Publicat: (2024-09-01)

Effect of smoking on disability progression in patients with multiple sclerosis
per: Tuncay Gündüz, et al.
Publicat: (2018-10-01)

The multiple sclerosis monitoring study: Progress to date
per: Cooper, C, et al.
Publicat: (2004)

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
per: Gavin Giovannoni, et al.
Publicat: (2022-06-01)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
per: Arun, T, et al.
Publicat: (2009)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
per: Suzi B. Claflin, et al.
Publicat: (2019-01-01)

Radiotherapy Improves the Disability in Patients with Secondary Progressive Multiple Sclerosis
per: Hossein-Ali Ebrahimi, et al.
Publicat: (2023-08-01)

Making the diagnosis of multiple sclerosis.
per: Palace, J
Publicat: (2001)

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
per: Ahmed Abdelhak, et al.
Publicat: (2024-02-01)

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
per: Yates, R, et al.
Publicat: (2017)

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.
per: Chen, J, et al.
Publicat: (2004)

Patient choice and adherence with disease-modifying therapy in multiple sclerosis
per: Burke, G, et al.
Publicat: (2004)

New and old treatments for multiple sclerosis.
per: Palace, J
Publicat: (1998)

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
per: Parry, A, et al.
Publicat: (2002)

Multiple sclerosis patients in Japan appear to have less disability compared to the UK
per: Kumar, G, et al.
Publicat: (2013)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
per: Katariina Hänninen, et al.
Publicat: (2020-07-01)

The UK Multiple Sclerosis database.
per: Palace, J, et al.
Publicat: (1999)

Genetic Factors Associated with Risk and Disability Progression of Multiple Sclerosis in Slovak Population
per: Hanysova Sandra, et al.
Publicat: (2017-08-01)

Estimating typical multiple sclerosis disability progression speed from clinical observations.
per: Murray G Brown, et al.
Publicat: (2014-01-01)

Guidelines for differential diagnosis of suspected multiple sclerosis.
per: Palace, J
Publicat: (2009)

New treatments and azathioprine in multiple sclerosis.
per: Palace, J, et al.
Publicat: (1997)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
per: Wakerley, B, et al.
Publicat: (2011)

DISABILITY PROGRESSION IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) WHO EXPERIENCE DISEASE ACTIVITY DESPITE PREVIOUS DISEASE MODIFYING THERAPY
per: Hettle, R, et al.
Publicat: (2011)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
per: Palace, J
Publicat: (2009)

Age and disability accumulation in multiple sclerosis.
per: Scalfari, A, et al.
Publicat: (2011)

Impairment, disability and fatigue in multiple sclerosis
per: Shahnaz Shahrbanian, et al.
Publicat: (2018-05-01)

The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis
per: Palace, J, et al.
Publicat: (2008)

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis
per: Gleb Makshakov, et al.
Publicat: (2017-01-01)

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
per: René-Maxime Gracien, et al.
Publicat: (2016-01-01)

Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning
per: Jean-Pierre R. Falet, et al.
Publicat: (2022-09-01)

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
per: Diego Cadavid, et al.
Publicat: (2013-01-01)

Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era
per: Ilya Kister, et al.
Publicat: (2018-09-01)

Association Between Sunlight Exposure and Vitamin D Intake and Multiple Sclerosis Disability and Progression
per: Emad Fayyazi, et al.
Publicat: (2018-08-01)

Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis
per: Maria N. Zakharova, et al.
Publicat: (2018-12-01)

Multiple sclerosis lesions: insights from imaging techniques.
per: Tomassini, V, et al.
Publicat: (2009)

Modafinil for multiple sclerosis fatigue: does it work?
per: Littleton, E, et al.
Publicat: (2010)

How patients with multiple sclerosis acquire disability
per: Lublin, FD, et al.
Publicat: (2022)

An approach to the identification of targets of autoantibodies in multiple sclerosis
per: Littleton, E, et al.
Publicat: (2004)

Brain atrophy and lesion load predict long term disability in multiple sclerosis.
per: Popescu, V, et al.
Publicat: (2013)